Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Integrase strand transfer refers to a critical step in the life cycle of retroviruses, such as HIV, where the viral enzyme integrase catalyzes the insertion (integration) of viral DNA into the host cell's genome. This process is essential for establishing a permanent infection and enabling viral replication. Drugs known as Integrase Strand Transfer Inhibitors (INSTIs) block this step by binding to integrase when it is associated with processed viral DNA, competing with target (host) DNA for binding at the active site, thereby preventing strand transfer and halting HIV replication.
INSTIs bind near/at catalytic Mg²⁺ ions in integrase-DNA complex after 3' processing; prevent access/binding of host genomic DNA required for strand transfer; specifically block only strand transfer.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIV Integrase Strand Transfer (None).